STRBP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.537400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.189800E-01
Normal-vs-Stage2
4.409400E-01
Normal-vs-Stage3
2.867000E-01
Normal-vs-Stage4
3.407600E-01
Stage1-vs-Stage2
7.547600E-01
Stage1-vs-Stage3
1.459170E-01
Stage1-vs-Stage4
7.390000E-01
Stage2-vs-Stage3
7.079600E-02
Stage2-vs-Stage4
9.177000E-01
Stage3-vs-Stage4
1.160040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.511200E-01
Normal-vs-AfricanAmerican
5.535400E-01
Normal-vs-Asian
5.126000E-01
Caucasian-vs-AfricanAmerican
5.162400E-01
Caucasian-vs-Asian
5.764000E-01
AfricanAmerican-vs-Asian
7.720800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.453000E-01
Normal-vs-Female
1.259840E-01
Male-vs-Female
6.795400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.301600E-01
Normal-vs-Age(41-60Yrs)
4.806000E-01
Normal-vs-Age(61-80Yrs)
4.458600E-01
Normal-vs-Age(81-100Yrs)
4.639000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.211400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.933600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.400400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.688000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.031400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.831200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.488600E-01
Normal-vs-Daily Drinker
4.233800E-01
Normal-vs-Weekly Drinker
3.733000E-01
Normal-vs-Occasional Drinker
6.348000E-01
Normal-vs-Social Drinker
4.415400E-01
Non Drinker-vs-Daily Drinker
6.880400E-01
Non Drinker-vs-Weekly Drinker
2.684800E-01
Non Drinker-vs-Occasional Drinker
3.021000E-01
Non Drinker-vs-Social Drinker
9.115400E-01
Daily Drinker-vs-Weekly Drinker
3.228600E-01
Daily Drinker-vs-Occasional Drinker
2.343800E-01
Daily Drinker-vs-Social Drinker
7.977400E-01
Weekly Drinker-vs-Occasional Drinker
1.340560E-01
Weekly Drinker-vs-Social Drinker
3.129200E-01
Occasional Drinker-vs-Social Drinker
2.872600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.018200E-01
Normal-vs-Grade 2
6.938500E-02
Normal-vs-Grade 3
4.310000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.880010E-01
Grade 1-vs-Grade 3
1.235230E-01
Grade 1-vs-Grade 4
3.018200E-01
Grade 2-vs-Grade 3
4.850200E-01
Grade 2-vs-Grade 4
6.938500E-02
Grade 3-vs-Grade 4
4.310000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.370000E-01
Normal-vs-NonDiabetic
4.557600E-01
Diabetic-vs-NonDiabetic
6.911600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.098800E-01
Normal-vs-NoPancreatitis
4.598400E-01
Pancreatitis-vs-NoPancreatitis
3.502600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.788800E-01
Normal-vs-N1
4.315400E-01
N0-vs-N1
2.178000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.863200E-01
Normal-vs-TP53-NonMutant
2.724000E-01
TP53-Mutant-vs-TP53-NonMutant
3.741800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
